IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BERRUTI, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.031
EU - Europa 7.445
AS - Asia 4.123
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 14
SA - Sud America 8
Totale 35.657
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.978
UA - Ucraina 2.684
CN - Cina 2.309
DE - Germania 1.131
HK - Hong Kong 986
PL - Polonia 869
IT - Italia 830
SG - Singapore 516
IE - Irlanda 507
GB - Regno Unito 431
FI - Finlandia 391
FR - Francia 187
RU - Federazione Russa 119
CZ - Repubblica Ceca 110
IN - India 110
VN - Vietnam 80
SE - Svezia 71
TR - Turchia 61
CA - Canada 52
BE - Belgio 49
NL - Olanda 30
AU - Australia 18
JP - Giappone 18
EU - Europa 16
CH - Svizzera 12
KR - Corea 11
IR - Iran 9
DK - Danimarca 5
MU - Mauritius 5
AZ - Azerbaigian 4
CL - Cile 4
ES - Italia 3
GR - Grecia 3
IQ - Iraq 3
BR - Brasile 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
ZA - Sudafrica 2
ZW - Zimbabwe 2
AL - Albania 1
AR - Argentina 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 35.657
Salva come PNG Salva come JPEG
Città #
Fairfield 4.232
Woodbridge 3.240
Houston 2.186
Ashburn 1.879
Jacksonville 1.876
Seattle 1.720
Cambridge 1.594
Ann Arbor 1.362
Wilmington 1.342
Hong Kong 982
Princeton 879
Warsaw 869
Chandler 727
Beijing 547
New York 515
Nanjing 469
Dublin 465
Helsinki 321
Singapore 309
Dearborn 199
Brescia 191
Des Moines 187
Nanchang 186
San Diego 181
Boardman 136
Shenyang 135
Changsha 134
Hebei 133
Shanghai 128
Milan 101
Brno 86
Jinan 86
Tianjin 82
London 81
Dong Ket 80
Jiaxing 67
Orange 56
Hangzhou 51
Kocaeli 51
Verona 50
Brussels 48
Kunming 47
San Francisco 43
Los Angeles 40
West Jordan 40
Washington 35
Rome 34
Ningbo 30
Toronto 29
Munich 27
Lanzhou 26
Nürnberg 26
Zhengzhou 25
Kilburn 24
Olomouc 24
Haikou 23
Naples 23
Norwalk 23
Menlo Park 22
Lancaster 20
Pune 20
Guangzhou 19
San Mateo 19
Taizhou 19
Redwood City 17
Changchun 16
Augusta 15
Hefei 15
Leawood 15
North York 15
Acton 14
Chicago 13
New Bedfont 13
Falls Church 12
Lappeenranta 12
Phoenix 12
Chiswick 11
Fuzhou 11
Dalmine 10
Mumbai 10
Prescot 10
Walnut 10
Canberra 9
Gumyojicho 9
Ardabil 8
Indiana 8
Melbourne 8
Napoli 8
Cazzago San Martino 7
Southwark 7
Turin 7
Vignate 7
Westminster 7
Fukuoka 6
Hounslow 6
Livorno 6
Brooklyn 5
Dietikon 5
Falkenstein 5
Parma 5
Totale 28.955
Salva come PNG Salva come JPEG
Nome #
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 231
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 207
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 200
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 181
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 178
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 172
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 168
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 163
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 162
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials 158
Immunotherapy failure in adrenocortical cancer: where next? 157
Excess of second tumors in denosumab-treated patients: A metabolic hypothesis 155
Pros-IT CNR: an Italian prostate cancer monitoring project 147
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 145
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 145
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 144
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 144
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 143
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 142
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 142
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 140
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 140
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 139
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 138
Regression of advanced neuroendocrine tumors among patients receiving placebo 137
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 134
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients 133
Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi method 131
Palbociclib inhibits proliferation of human adrenocortical tumor cells 131
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 129
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 127
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 126
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 124
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 124
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 123
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 123
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 123
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 122
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 122
Exemestane with ovarian suppression in premenopausal breast cancer. 122
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 121
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 121
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 119
Serum vitamin D and prostate cancer prognosis: The story continues 119
Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer 119
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 119
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 117
Prognostic factors in patients receiving third-line targeted therapy for metastatic renal cell carcinoma. 116
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 116
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 115
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 115
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 114
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients 114
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 112
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 111
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 111
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 110
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer. 109
Case-control study of the impact of adjuvant hormone therapy in prostate cancer patients on quality of life, anxiety and depression and self body image perception 109
Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases. 109
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 109
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 108
A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report 108
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 107
The pathological diagnosis of neuroendocrine tumors: Common questions and tentative answers 107
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: A double-blind, randomised, phase 3 study 106
Mediastinal non-seminomatous germ cell tumours: effectiveness of platinum, etoposide, bleomycin combination chemotherapy plus adjunctive surgery. 106
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 106
Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatment. 105
Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancer. 105
Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. 105
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 105
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. 104
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 104
An unusual case of a well-differentiated neuroendocrine tumour of the ileum with peritoneal carcinomatosis: A case report 103
Combination chemotherapy in advanced adrenocortical carcinoma 103
Follow-up and quality of life 103
5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma 103
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study. 103
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 103
Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results? 102
Gonadal function in male patients with metastatic renal cell cancer treated with sunitinib: Effects of testosterone replacement on quality of life. 102
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 102
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): An European Network for the Study of Adrenal Tumor (ENSAT) study 102
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization. 101
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma 101
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 101
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 101
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain. 100
Adjuvant mitotane treatment for adrenocortical carcinoma 100
Abiraterone and increased survival in metastatic prostate cancer 100
Real-world study of everolimus in advanced progressive neuroendocrine tumors. 99
Potential clinical value of circulating chromogranin A in patients with prostate carcinoma. 99
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis 99
Effect of primary letrozole treatment on tumor expression of mTOR and HIF-1α and relation to clinical response 99
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 99
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. 98
PROGNOSTIC ROLE OF SERUM TESTOSTERONE LEVELS IN PROSTATE CANCER PATIENTS DURING ANDROGEN-DEPRIVATION THERAPY 98
Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures? 98
Adjunctive treatment of adrenocortical carcinoma 98
Totale 12.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 180.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.514 1.300 346 405 1.154 721 1.256 1.096 1.167 1.038 1.093 336 602
2020/20217.465 202 836 390 854 400 777 392 786 619 1.174 650 385
2021/20223.503 274 702 93 213 50 182 214 234 194 349 267 731
2022/20232.588 497 83 74 178 191 712 12 212 347 44 115 123
2023/20243.981 180 97 317 217 207 696 109 145 1.051 120 50 792
2024/202547 47 0 0 0 0 0 0 0 0 0 0 0
Totale 36.583